Search Results

Bioland Blood Pressure Monitor Model 2001, Model 2003, Model 2004, Model 2005, model 3000, Model 3001 and Model 3002, are Sphygmomanometer with Electronic Manometer ntended to be used for the indirect (non-invasive) measurement of diastohc, systolic blood pressure and pulse rate for adults only.

Bioland Blood Pressure Monitor Model 2001, Model 2003, Model 2005, model 3000, Model 3001 and Model 3002, are Sphygmomanometers with Electronic Manometer intended to be used for the indirect (non-mvasive) measurement of diastohe, systolic blood pressure and pulse rate for adults only.

Bioland Blood Pressure Montor Model 2001 and Model 2004 respectively use an inflation cuff wrapped around the upper arm The cuff is inflated by a manual air pump

Bloland Blood Pressure Monitor Model 2003 and Model 2005 respectively use an inflation cuff wrapped around the upper arm. The cuff is inflated by an electrical air pump

Bioland Blood Pressure Montor Model 3000, Model 3002, respectively uses inflation cuffs wrapped around the wrists. The cuff is inflated automatically by an electrical arr pump

The systolic, diastolic blood pressures and heart beats are transmitted via air pressure in the mflated cuff to transducer for the determination with oscillometric method. The cuff integrated with bladder is inflated by arr pump The deflation rate is controlled and released by a preset mechanical valve at a constant rate beginning at the pressure peak during the measurement results including dastolic. systolic pressures and heart pulse rate are displayed on the LCD

Here's an analysis of the acceptance criteria and study detailed in the provided 510(k) summary for the Bioland Blood Pressure Monitor models:

Acceptance Criteria and Device Performance for Bioland Blood Pressure Monitors

1. Table of Acceptance Criteria and Reported Device Performance

The acceptance criteria for the Bioland Blood Pressure Monitors are primarily based on the ANSI/AAMI SP-10 standard and FDA guidance "Non-invasive Blood Pressure (NIBP) Monitor Guidance". The clinical performance is evaluated against the accuracy of a mercury-type sphygmomanometer.

2. Sample Size Used for the Test Set and Data Provenance

• Sample Size: The clinical test involved 87 patients for each group of models (Model 2001/2003, Model 2004/2005, Model 3000/3001/3002). It is not explicitly stated if these are unique patients across all model groups or if the same 87 patients were tested with different models. Assuming 87 unique patients for each grouped model as presented.
• Data Provenance: The study was conducted in Feng Gang Overseas Chinese Hospital. The type of study (retrospective or prospective) is not explicitly stated, but clinical tests are typically prospective. The country of origin is implicitly China, given the hospital's name and location.

3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of those Experts

The ground truth was established by "normal mercury-type sphygmomanometers." This implies that the measurements were taken by healthcare professionals trained in using these devices. The document does not specify the number of experts, their qualifications (e.g., specific medical titles, years of experience), or if multiple experts were involved in taking reference measurements for the same patient.

4. Adjudication Method for the Test Set

The document does not explicitly state an adjudication method (like 2+1, 3+1, or none) for establishing ground truth measurements from the mercury sphygmomanometers. It simply refers to "comparing to normal mercury-type sphygmomanometers," which suggests that the direct readings from these reference devices were used.

5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study was done

No, a multi-reader multi-case (MRMC) comparative effectiveness study was not done. The study compares the device's measurements against a reference standard (mercury sphygmomanometer), not against human readers' performance with and without AI assistance. This device is a standalone measurement system, not an AI-assisted diagnostic tool for human interpretation.

6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) was done

Yes, a standalone performance study was done. The Bioland Blood Pressure Monitors are automatic devices that measure blood pressure using an oscillometric method. The clinical tests evaluate the accuracy of these devices' measurements (algorithm only) compared to the ground truth established by mercury sphygmomanometers, without human intervention in operating the device or interpreting its output.

7. The Type of Ground Truth Used

The ground truth used was "normal mercury-type sphygmomanometers." This is an accepted and common reference standard for non-invasive blood pressure measurement devices.

8. The Sample Size for the Training Set

The document does not provide information regarding a separate training set or its sample size. This is a medical device clearance, and the focus is on the validation/test set performance against established clinical and engineering standards. For such devices, manufacturers typically use proprietary algorithms developed with internal data, and the submission primarily demonstrates performance on a separate, independent test set.

9. How the Ground Truth for the Training Set was Established

Since information about a specific training set is not provided, the method for establishing its ground truth is also not detailed in this summary.

Ask a specific question about this device